Assessment of Cerebrospinal Fluid Neurogranin as a Predictor of Alzeheimer’s Disease Through Synaptic Dysfunction

International Journal of Neurosurgery
doi 10.11648/j.ijn.20180201.13
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Science Publishing Group

Related search

Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease

JAMA Neurology
Neurology
2015English

Cerebrospinal Fluid Neurogranin and YKL-40 as Biomarkers of Alzheimer's Disease

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2015English

Electroconvulsive Therapy Does Not Alter the Synaptic Protein Neurogranin in the Cerebrospinal Fluid of Patients With Major Depression

Journal of Neural Transmission
PsychiatryMental HealthNeurologyBiological Psychiatry
2017English

Erectile Dysfunction as a Predictor of Cardiovascular Disease

International Journal of Impotence Research
Urology
2008English

Cerebrospinal Fluid Outflow Resistance as a Diagnostic Marker of Spontaneous Cerebrospinal Fluid Leakage

Journal of Neurosurgery: Spine
MedicineSurgeryNeurology
2017English

Intracellular Accumulation of Amyloid-Beta – A Predictor for Synaptic Dysfunction and Neuron Loss in Alzheimer’s Disease

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2010English

Longitudinal Assessment of Tau and Amyloid Beta in Cerebrospinal Fluid of Parkinson Disease

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2013English

65: Defecatory Dysfunction as a Predictor of Pessary Failure

American Journal of Obstetrics and Gynecology
GynecologyObstetrics
2018English

Cerebrospinal Fluid P-Tau217 Performs Better Than P-Tau181 as a Biomarker of Alzheimer’s Disease

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy